Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hepatitis B immune globulin.

Shahid Habib¹, Obaid S Shaikh

¹Center for Liver Diseases, Iowa Health Des Moines, Des Moines, IA, USA.

Drugs of Today (Barcelona, Spain : 1998)

|July 7, 2007

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hepatitis C and risk of tuberculosis amongst United States veterans: a national cohort study.

Lancet regional health. Americas·2026

Same author

Increased Mortality with Intermediate Ascitic Polymorphonuclear Cell Counts Amongst Patients with Cirrhosis: Time to Redefine the Care Approach.

Pathophysiology : the official journal of the International Society for Pathophysiology·2025

Same author

Hepatocellular Carcinoma Among Patients With Metabolic Dysfunction Associated Steatotic Liver Disease.

Gastro hep advances·2025

Same author

The Debilitating Impact of Transphobia on Health Care Services: The Moderated Mediation Model of Transphobia, Minority Stress, Social Exclusion, and Access to Health Care among People Who Are Transgender.

International journal of social determinants of health and health services·2025

Same author

Hepatitis Delta Coinfection Rates and All-Cause Mortality Among Hepatitis B-Infected Veterans in the USA.

Journal of viral hepatitis·2024

Same author

COVID-19 Disease Incidence and Severity in Persons Previously Infected and Unvaccinated vs Previously Uninfected and Vaccinated.

The Journal of infectious diseases·2024

Same journal

Monoclonal antibodies for treatment of osteoporosis.

Drugs of today (Barcelona, Spain : 1998)·2023

Same journal

Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.

Drugs of today (Barcelona, Spain : 1998)·2023

Same journal

Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer.

Drugs of today (Barcelona, Spain : 1998)·2023

Same journal

Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.

Drugs of today (Barcelona, Spain : 1998)·2023

Same journal

Mitapivat for sickle cell disease and thalassemia.

Drugs of today (Barcelona, Spain : 1998)·2023

Same journal

Cenegermin for the treatment of dry eye disease.

Drugs of today (Barcelona, Spain : 1998)·2023

See all related articles

Hepatitis B immune globulin (HBIG) provides passive immunity against Hepatitis B virus infection by neutralizing the virus. HBIG is recommended for post-exposure prophylaxis, not for treating active Hepatitis B infections.

Area of Science:

Immunology
Virology
Hepatology

Background:

Hepatitis B immune globulin (HBIG) is a concentrated solution of antibodies against the Hepatitis B surface antigen (anti-HBs).
It is sourced from plasma of individuals with confirmed immunity to Hepatitis B virus (HBV).
HBIG confers temporary, passive immunity by neutralizing HBV virions.

Purpose of the Study:

To outline the recommended clinical applications of HBIG.
To clarify the role of HBIG in preventing Hepatitis B virus infection.

Main Methods:

Review of clinical guidelines and scientific literature on HBIG usage.
Analysis of HBIG's mechanism of action in providing passive immunity.

Main Results:

Related Experiment Videos

HBIG is effective in providing passive prophylactic immunity against HBV.
HBIG is not a treatment for acute or chronic Hepatitis B.
Recommended uses include post-exposure prophylaxis (PEP) after HBV exposure and in specific high-risk scenarios.

Conclusions:

HBIG is a crucial tool for preventing Hepatitis B virus infection in specific exposure situations.
Its appropriate use is vital for managing Hepatitis B virus exposure and preventing infection.